|
Symbiotec Pharmalab Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
7480.70 Cr.
|
P/BV
|
6.50
|
Book Value (Rs.)
|
178.98
|
|
52 Week High/Low (Rs.)
|
1310/934
|
FV/ML
|
2/1
|
P/E(X)
|
68.08
|
|
Bookclosure
|
|
EPS (Rs.)
|
17.10
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 218.15 | 245.25 | 203.17 |
| Total Income From Operations | 218.15 | 245.25 | 203.17 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 102.96 | 91.12 | 77.33 |
| Increase/Decrease in Stocks | -27.40 | 0.00 | 0.00 |
| Employees Cost | 46.42 | 42.33 | 35.14 |
| Depreciation | 21.82 | 19.75 | 10.51 |
| Other Expenses | 50.97 | 49.71 | 32.74 |
| Total Expenses | 194.78 | 202.91 | 155.71 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 23.37 | 42.34 | 47.46 |
| Other Income | 0.34 | 0.16 | 2.64 |
| P/L Before Interest, Excpt. Items & Tax | 23.71 | 42.50 | 50.10 |
| Interest | 6.18 | 7.26 | 5.28 |
| P/L Before Exceptional Items & Tax | 17.53 | 35.25 | 44.82 |
| P/L Before Tax | 17.53 | 35.25 | 44.82 |
| Tax | 3.47 | 7.71 | 14.90 |
| P/L After Tax from Ordinary Activities | 14.06 | 27.53 | 29.92 |
| Net Profit/Loss For the Period | 14.06 | 27.53 | 29.92 |
| Minority Interest | -0.01 | -0.02 | 0.00 |
| Net P/L After Minority Interest & Share Of Associates | 14.06 | 27.51 | 29.92 |
| | | | |
| Equity Share Capital | 12.55 | 12.55 | 10.94 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | 2.24 | 4.78 | 5.37 |
| Diluted EPS (Rs.) | 2.24 | 4.76 | 5.34 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | 2.24 | 4.78 | 5.37 |
| Diluted EPS (Rs.) | 2.24 | 4.76 | 5.34 |
| | | | |
| PBITOE Margin (%) | 10.71 | 17.26 | 23.35 |
| PBTE Margin (%) | 8.03 | 14.37 | 22.06 |
| PBT Margin (%) | 8.03 | 14.37 | 22.06 |
| PAT Margin (%) | 6.44 | 11.22 | 14.72 |
| PAT After MI And SOA Margin (%) | 6.44 | 11.21 | 14.72 |
